J&J Scoops Up Abiomed for $16.6B Cash

Johnson & Johnson, already a sterling presence in the upper echelon of the consumer health space, is set to dole out around $16.6 billion in cash for heart pump manufacturer Abiomed. The latter’s Impella pumps, used in the U.S. for nearly 15 years, are famous for being the smallest in the world...